Products
| Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(meta-nitrophenyl)-3,5-pyridinedicarboxylate | |
| Product name | Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(meta-nitrophenyl)-3,5-pyridinedicarboxylate |
| Chinese name | 硝苯乙吡啶；2,6-二甲基-4-(3-硝基苯基)-1,4-二氢-3,5-吡啶二甲酸甲乙酯；硝苯甲乙吡啶；2,6-二甲基-4-(3-硝基苯基)-L,4-二氢-3,5-吡啶二羧酸甲乙酯；1,4-二氢-2,6-二甲基-4-(3-硝基苯)-3,5-吡啶二羧酸乙基甲酯；乐卡地平甲基乙基酯杂质 |
| English name | Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(meta-nitrophenyl)-3,5-pyridinedicarboxylate |
| Molecular formula | C18H20N2O6 |
| Molecular weight | 360.36 |
| CAS No. | 39562-70-4 |
| Product photo |  |
| Structure |  |
| chemical properties | No smell or taste. Case of light metamorphism. Soluble in acetone or chloroform, slightly soluble in methanol or ethanol, a few insoluble in water. |
| Appearance | Yellow crystal or crystalline powder |
| Melting point | 158°C |
| Content | BP/EP/CP |
| Moisture | |
| Packing | 1kg，5kg，25kg |
The other explanation |
Uses: second generation calcium antagonists, for the treatment of high blood pressure than the ideal drug. There is a significant and long-lasting antihypertensive and vascular contraction. Applicable to all types of hypertension, such as primary and secondary light, moderate hypertension, can also be used for coronary heart disease, congestive heart failure, etc.. |
